Gaudium IVF Refiles IPO Papers with SEBI, Aims to Raise Funds for Expansion
Gaudium IVF and Women Health Ltd has refiled its IPO draft papers with SEBI. The IPO includes a fresh issue of 1.14 crore equity shares and an offer for sale of 95 lakh shares by the promoter. Funds will be used to establish 19 new IVF centers and repay debt. The company operates 7 hubs and 28 spokes across India. Financial performance shows strong growth with revenue increasing from INR 47.89 crore to INR 70.72 crore, and profit after tax rising from INR 10.31 crore to INR 19.13 crore. The Indian IVF market is projected to grow at a 13% CAGR, reaching USD 4.54 billion by 2034.
*this image is generated using AI for illustrative purposes only.
Gaudium IVF and Women Health Ltd, a prominent player in the Indian fertility treatment sector, has taken a significant step towards going public by refiling its draft papers with the Securities and Exchange Board of India (SEBI) for an Initial Public Offering (IPO).
IPO Structure
The proposed IPO comprises two components:
- A fresh issue of 1.14 crore equity shares
- An offer for sale of nearly 95 lakh equity shares by the company's promoter, Manika Khanna
Fund Utilization
The company has outlined clear objectives for the funds raised through the fresh issue:
- INR 50 crore will be allocated for establishing 19 new IVF centres across India, significantly expanding its footprint
- INR 20 crore is earmarked for debt repayment, which could strengthen the company's financial position
Company Operations
Gaudium IVF operates through an efficient hub-and-spoke model:
- 7 hubs
- 28 spokes across multiple states
This structure allows the company to maintain a wide reach while centralizing key resources and expertise.
Financial Performance
The company has demonstrated strong financial growth:
| Fiscal Year | Revenue (INR Crore) | Profit After Tax (INR Crore) |
|---|---|---|
| FY25 | 70.72 | 19.13 |
| FY24 | 47.89 | 10.31 |
This represents a significant year-over-year increase in both revenue and profitability, indicating robust business growth.
Market Outlook
The Indian IVF market shows promising growth prospects:
- Projected to grow at a 13% CAGR
- Expected to expand from USD 1.32 billion in 2024 to USD 4.54 billion by 2034
This positive market outlook could potentially benefit companies like Gaudium IVF that are positioned to capture this growth.
IPO Details
Sarthi Capital Advisors has been appointed as the sole book running lead manager for the IPO, overseeing the offering process.
The refiling of IPO papers by Gaudium IVF and Women Health Ltd marks a significant milestone for the company. As the Indian IVF market continues to grow, this expansion-focused offering will likely be closely watched by investors in the coming months.
17
